Immunophotonics is a startup based in the United States, 1 tracked investor.
Immunophotonics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Immunophotonics develops Interventional Immuno-Oncology® therapeutics using a proprietary glycan polymer platform designed to stimulate immune responses to fight cancer and other diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.